Funding round brings in $6.4M for developer of Alzheimer's drug

05/7/2013 | MedCityNews.com

NeuroPhage Pharmaceuticals secured $6.4 million in a funding round led by Mérieux Développement. The company will use the proceeds to advance development of its potential Alzheimer's drug NPT002, which is in preclinical development. The firm plans to submit an investigational new drug application and begin clinical trials next year.

View Full Article in:

MedCityNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President, Science and Regulatory Affairs
American Beverage Association
Washington, DC
Senior Manager of Medical Management
Network Health
Medford, MA
MEDICAL SCIENCE LIAISON - 14000002RO
Abbott
Columbus, OH
Manager, Medical Management
Network Health
Medford, MA
Executive Medical Director
Aspirus Network Inc
Wausau, WI